AU4563599A - Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx - Google Patents

Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx

Info

Publication number
AU4563599A
AU4563599A AU45635/99A AU4563599A AU4563599A AU 4563599 A AU4563599 A AU 4563599A AU 45635/99 A AU45635/99 A AU 45635/99A AU 4563599 A AU4563599 A AU 4563599A AU 4563599 A AU4563599 A AU 4563599A
Authority
AU
Australia
Prior art keywords
esx
exon
polypeptide
nucleic acid
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45635/99A
Other languages
English (en)
Inventor
Christopher C. Benz
Chuan-Hsiung Chang
Yesu Chao
Gary K. Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU4563599A publication Critical patent/AU4563599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU45635/99A 1998-06-16 1999-06-15 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx Abandoned AU4563599A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8940998P 1998-06-16 1998-06-16
US60089409 1998-06-16
US28953599A 1999-04-09 1999-04-09
US09289535 1999-04-09
PCT/US1999/013277 WO1999065929A1 (fr) 1998-06-16 1999-06-15 Les exons 4 et 7 codent pour des domaines distincts de transactivation et de localisation de la chromotine dans le facteur esx

Publications (1)

Publication Number Publication Date
AU4563599A true AU4563599A (en) 2000-01-05

Family

ID=26780560

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45635/99A Abandoned AU4563599A (en) 1998-06-16 1999-06-15 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx

Country Status (4)

Country Link
EP (1) EP1087985A1 (fr)
AU (1) AU4563599A (fr)
CA (1) CA2331266A1 (fr)
WO (1) WO1999065929A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058468A2 (fr) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 47 proteines humaines secretees
EP1366072A2 (fr) * 2000-11-02 2003-12-03 Myocontract Ag Promoteur specifique de compose relie au facteur de transcription ets, et transactivateurs associes
AU2002337831A1 (en) * 2001-10-12 2003-05-06 Beth Israel Deaconess Medical Center, Inc. Methods of diagnosis of autoimmune disease
EP1934363B1 (fr) 2005-09-12 2013-03-20 The Regents Of The University Of Michigan Fusion geniques recurrentes dans le cancer de la prostate
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
ATE533861T1 (de) 2007-07-06 2011-12-15 Univ Michigan Mipol1-etv1-gen-neuanordnungen
US8106037B2 (en) 2007-08-03 2012-01-31 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
AU2010295689B2 (en) 2009-09-17 2014-02-13 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
WO2014159813A1 (fr) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Molécules polynucléotidiques à longue durée de vie
US9341639B2 (en) 2013-07-26 2016-05-17 Industrial Technology Research Institute Apparatus for microfluid detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789200A (en) * 1996-10-31 1998-08-04 Smithkline Beecham Corporation Human ETS family member, ELF3

Also Published As

Publication number Publication date
WO1999065929A1 (fr) 1999-12-23
EP1087985A1 (fr) 2001-04-04
CA2331266A1 (fr) 1999-12-23

Similar Documents

Publication Publication Date Title
US7125969B1 (en) ETS-related gene overexpressed in human breast and epithelial cancers
KR100331363B1 (ko) 사이클린복합체재배열및그것과관련된용도
ES2321954T3 (es) Composiciones y procedimientos para el diagnostico de tumores.
WO1998023782A9 (fr) Nouveau gene lie a la famille ets, surexprime dans les cancers humains du sein et de l'epithelium
AU675678B2 (en) Transcription factor DP-1
US20030028905A1 (en) Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
EP1235934B1 (fr) Procede de criblage pour medicaments candidats
AU4563599A (en) Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx
Saisanit et al. Regulation of the pro-B-cell-specific enhancer of the Id1 gene involves the C/EBP family of proteins
US6448020B1 (en) Molecules associated with the human suppressor of fused gene
US20040028684A1 (en) Cancer diagnosis and assays for screening anti-cancer agents
WO2000075184A9 (fr) Modulation de taux de proteines au moyen du complexe scf
US20060199781A1 (en) Assays based on BTF3 activity
US6869766B2 (en) Gene associated with regulation of adiposity and insulin response
US7910704B2 (en) Human p53 splice variant displaying differential transcriptional activity
WO1999032609A1 (fr) Molecules associees au gene fusionne humain
WO1997043414A2 (fr) Gene suppresseur du carcinome basocellulaire
US7160677B1 (en) Transcription factor DP-1
ES2259058T3 (es) Gen amplificado en tumores, y materiales y procedimientos relacionados.
EP0964925A2 (fr) x

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted